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Clinical acid-base disorders:
Traditional versus “new”
analytical models
To the Editor: I have taught acid-base physiology to
medical students, residents, fellows, and practicing clini-
cians for many years. Although this is often an initially
confusing topic for many of these individuals, after sev-
eral lectures, a few case examples, and some practical ex-
perience, most are soon able to successfully dissect even
very complex mixed acid-base disorders. Measurements
of arterial pH, pCO2, and calculated or measured HCO3,
together with calculation of the anion gap and knowl-
edge of several empiric compensation rules, allows most
clinicians to fully explain virtually all acid-base pertur-
bations. Over the past few decades a number of “new”
approaches have been proposed, including “whole-blood
buffer base” of Singer and Hastings and “standard bicar-
bonate” and “base excess” of Astrup. In a recent per-
spective discussion, Corey [1] claims that a now classic
editorial by Schwartz and Relman [2] concluded “ . . . base
excess has conquered its rivals to form the cornerstone
of standard clinical acid-base chemistry.” The editorial
actually says the opposite! Indeed, it concludes that “the
traditional measurements of pH, pCO2, and plasma bi-
carbonate concentration continue to be the most reliable
biochemical guides in the analysis of acid-base distur-
bances.” More recently, a number of clinicians, including
Corey, have suggested we adopt the “Stewart” approach,
which analyzes three “independent variables:” “strong
ion difference,” “total weak acids,” and pCO2. The
Stewart approach may be mathematically correct but
I believe it adds little to the clinical interpretation of acid-
base disorders and markedly increases complexity.
It is claimed that the “Stewart” approach elucidates
certain complex disorders, yet I have still not encountered
a case where this is true. For example, Corey presents the
following case: “a critically ill patient with septic shock
and multiple organ failure . . . on cardiopressors, mechan-
ical ventilation, antibiotics, and large volumes of normal
saline. Na 130, K 3.0, Cl 111, albumin 1.5 g%, phosphate
2.0 mg%, HCO3 = 9.25, pCO2 = 30, pH = 7.1.” My in-
terpretation is—metabolic acidosis with inadequate res-
piratory compensation (respiratory acidosis). The anion
gap is about 10 (I prefer the equation AG = Na – (HCO3
+ Cl)). His albumin is reduced to 1.5 g% so his “base-
line” anion gap should be about 4. The AG is therefore
increased by about 6 and would account for a portion
of the fall in HCO3 (from 24 to about 18). His chlo-
ride concentration is also increased relative to sodium
and explains the rest of the fall in HCO3 (from 18 to 9).
The “traditional” approach therefore says the patient has
an anion gap metabolic acidosis (probably lactic), a hy-
perchloremic metabolic acidosis (possibly diarrhea, renal
tubular, and/or a component of “NaCl expansion”), and
respiratory acidosis due to lung and/or brain dysfunction.
Therefore, I strongly disagree with Corey’s statement
“ . . . that the traditional model offers no further insight
into the mechanism of the acid-base disorder.” Indeed,
what does the “Stewart” approach add to my analysis?
It may be mathematically correct, but it is bound to in-
troduce further confusion to an already confusing area
of medicine. Einstein said “Make everything as simple as
possible, but not simpler,” and I would add a corollary,
“Don’t needlessly make things more complex than they
need to be.”
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I would like to thank Professor Emmett for his com-
ments. First, he concedes that the Stewart approach is
sound mathematically. Second, as a proponent of the
“Boston” school he implies that base excess is an im-
perfect parameter to describe acid-base balance. Third,
he demonstrates that the anion gap may be unhelpful
if uncorrected for serum albumin. Lastly, he invokes
Stewart’s Strong Ion Difference (“chloride concentration
is also increased relative to sodium”) to explain “the rest
in the fall in HCO3” in the problem case under discussion.
In essence, I believe that Professor Emmett has summa-
rized quite nicely the major thesis of my review.
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Now for the “complexity issue,” which I believe is Pro-
fessor Emmett’s major criticism of Stewart’s theory. Just
as Newtonian physics may be regarded as a subset of
Einstein’s relativity, the traditional model of acid-base
balance may be thought of as a subset of Stewart’s
more general theory. Professor Emmett is correct in that
both Newtonian physics and traditional acid-base theory
are useful to describe commonly observed phenomenon.
However, in actuality, light bends and so does the buffer
curve. In the era of the palmtop computer, mathematical
complexity should not impede progress either in physics
or in physiology.
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CD28− T cells display features
of effector memory T cells in
Wegener’s granulomatosis
To the Editor: We read with interest the article by Vogt
et al [1], who found shortening of telomers and reduced
CD28 expression on T-cells in Wegener’s granulomatosis
(WG). Several groups have shown an expansion of cir-
culating CD8+ and CD4+ T-cells lacking the costimula-
tory molecule CD28 in WG. The expansion of circulating
CD28− T-cells is already evident in patients with initial
disease manifestations and correlates with organ involve-
ment [2]. CD4+CD28− and CD8+CD28− T-cells are en-
riched in broncho-alveolar lavage fluid. In granulomatous
lesions of the respiratory tract in WG, T-cells completely
lack CD28 expression. Circulating peripheral blood and
granuloma CD4+CD28− T-cells are a major source of
Th1-type cytokine secretion [3]. The Th1-type chemokine
receptor CCR5 is expressed on CD28− T-cells and may
favor recruitment of CD28− T-cells into inflammatory le-
sions [2]. Of note, circulating CD4+CD28− T-cells ex-
press the differentiation marker CD57 (HNK-1) and the
activation marker CD18 (b2-integrin). The expression of
these cell surface markers and the restriction of Th1-type
cytokine production to IFN-c and TNF-a and perforin
expression of CD4+CD28− T-cells in WG is typical of so-
called late differentiated or effector memory T-cells [3].
Shortening of telomer length as a sign of replicative senes-
cence of T-cells is in line with the finding of an expanded
subset of effector memory T-cells. CD8+CD28− cells dis-
play heterogeneous CD27 expression, features which are
also seen in antigen-specific (cytomegalovirus-) T-cells in
WG, but not in controls, suggesting profound generalized
changes in the CD8+ T-cell compartment also affecting
virus-specific T-cell responses in WG [4].
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We appreciate the comment and the reference to
the publications—cited as [2] and [4]—which were not
yet available when we were submitting our manuscript.
Basically, we agree that there are small numbers of
CD4+CD28− T-cells in patients with Wegener’s gran-
ulomatosis (5.4% as cited by Lamprecht et al [1] and
approximately 3% in our study). The more intriguing
finding of our study, however, is that the majority of
CD28− cells are CD8+ T-cells. They amount to 60% in
some patients (mean 45.2 ± 15.5, N = 22). Since sub-
mission of our manuscript, several publications dealing
with the identification of CD28− T-cells have appeared,
and there is now increasing evidence that these represent
memory/effector cells [2, 3]. Following antigenic chal-
lenge, naive T-cells enter a program of differentiation and
proliferation, and ultimately become memory cells. These
cells do not have short telomeres; there is, however, evi-
dence for increased division rates, as seen by reduced lev-
els of T-cell receptor excision cycles [4]. It is reasonable to
assume that during long-term, severe chronic inflamma-
tory disease, as in Wegener’s granulomatosis, these cells
eventually reach their finite number of cell divisions and
enter a state of senescence associated with shortening of
the telomeres. This assumption is in accordance with the
data derived from studies on persistent (virus) infection
[3, 5].
